INSM Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Insmed Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 25.535 USD -0.06%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 45.008 USD with a low forecast of 35.35 USD and a high forecast of 57.75 USD.

INSM Lowest Forecast

Wall Street Target

INSM Average Forecast

Wall Street Target

INSM Highest Forecast

Wall Street Target

38% Upside

76% Upside

126% Upside

The latest public price target was made on Apr 23, 2024 by Nicole Germino from Truist Financial , who expects INSM stock to rise by 88% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Nicole Germino Truist Financial	48 USD Upside 88%	1 week ago Apr 23, 2024	Truist Securities Starts Insmed (INSM) at Buy StreetInsider
Tiago Fauth Wells Fargo	55 USD Upside 115%	1 month ago Apr 1, 2024	Wells Fargo Adds Insmed (INSM) to Q2 '24 Tactical Idea List StreetInsider

Price Target	48 USD
Upside/Downside	88%

Price Target	55 USD
Upside/Downside	115%

GenMont Biotech Inc

347% Upside

Metagenomi Inc

263% Upside

Pharming Group NV

106% Upside

Curis Inc

38% Upside

GenMont Biotech Inc

347% Upside

Metagenomi Inc

263% Upside

Pharming Group NV

106% Upside

Curis Inc

38% Upside

Enlivex Therapeutics Ltd

341% Upside

Precision BioSciences Inc

220% Upside

Roivant Sciences Ltd

45% Upside

Genoway SA

62% Upside

Revenue
Forecast

The compound annual growth rate of Insmed Inc's revenue for the next 3 years is 41%.

N/A

41%

-1%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

0%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-41%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for INSM is 45.008 USD with a low forecast of 35.35 USD and a high forecast of 57.75 USD.

The compound annual growth rate of Insmed Inc's revenue for the next 3 years is 41%.

Join more than 134,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.